Michael E. Williams
Impact in
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 29
- Genetics 18
- Chronic Lymphocytic Leukemia Research 18
- Co-authors
- Ronald Levy (3 shared papers)Brian K. Link (3 shared papers)Christine A. White (2 shared papers)A.J. Grillo-López (2 shared papers)B.K. Dallaire (1 shared paper)Isabelle Bence‐Bruckler (1 shared paper)M. S. Czuczman (1 shared paper)Peter McLaughlin (1 shared paper)
- Journals
- Journal of Clinical Oncology (13 papers)Blood (6 papers)Current Treatment Options in Oncology (2 papers)The American Journal of the Medical Sciences (1 paper)British Journal of Haematology (1 paper)
- Partner nations
- United StatesAustriaTürkiye
In The Last Decade
Michael E. Williams
43 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Genetics 1.8k
- Pathology and Forensic Medicine 2.5k
- Hematology 965
- Oncology 2.2k
- Immunology 834
Countries citing papers authored by Michael E. Williams
This map shows the geographic impact of Michael E. Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Williams more than expected).
Fields of papers citing papers by Michael E. Williams
This network shows the impact of papers produced by Michael E. Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Williams. The network helps show where Michael E. Williams may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael E. Williams, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. Hit paper breakdown → | 1998 | 2153 |
| 2 | Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial Hit paper breakdown → | 2009 | 673 |
| 3 | 2013 | 264 | |
| 4 | 2008 | 250 | |
| 5 | 2008 | 236 | |
| 6 | 1999 | 225 | |
| 7 | 2014 | 138 | |
| 8 | 1995 | 124 | |
| 9 | 2013 | 83 | |
| 10 | 2011 | 81 | |
| 11 | 1988 | 39 | |
| 12 | 2015 | 29 | |
| 13 | 1994 | 25 | |
| 14 | 2011 | 23 | |
| 15 | 2009 | 20 | |
| 16 | 1980 | 20 | |
| 17 | 2013 | 14 | |
| 18 | 1996 | 13 | |
| 19 | 2012 | 13 | |
| 20 | 1985 | 11 |
About Michael E. Williams
Michael E. Williams is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Hematology and Molecular Biology, having authored 43 papers that have together received 4.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (29 papers), Chronic Lymphocytic Leukemia Research (18 papers), CAR-T cell therapy research (6 papers), Viral-associated cancers and disorders (5 papers), Lung Cancer Treatments and Mutations (5 papers), Multiple Myeloma Research and Treatments (5 papers), CNS Lymphoma Diagnosis and Treatment (4 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Genetics (1.8k citations), Pathology and Forensic Medicine (2.5k citations), Hematology (965 citations), Oncology (2.2k citations) and Immunology (834 citations). Michael E. Williams has collaborated with scholars based in United States, Austria and Türkiye. Frequent co-authors include Ronald Levy, Brian K. Link, Christine A. White, A.J. Grillo-López, B.K. Dallaire, Isabelle Bence‐Bruckler, M. S. Czuczman, Peter McLaughlin, Anthony D. Ho and Meyer R. Heyman. Their work appears in journals such as Journal of Clinical Oncology, Blood, Current Treatment Options in Oncology, The American Journal of the Medical Sciences and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.